Susquehanna International Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
+69,814
| New | +$202K | ﹤0.01% | 5538 |
|
|
2025
Q1 | – | Sell |
-29,755
| Closed | -$30.6K | – | 7056 |
|
|
2024
Q4 | $30.6K | Sell |
29,755
-14,464
| -33% | -$14.9K | ﹤0.01% | 5954 |
|
|
2024
Q3 | $59.3K | Buy |
44,219
+21,146
| +92% | +$28.3K | ﹤0.01% | 5256 |
|
|
2024
Q2 | $30K | Buy |
+23,073
| New | +$30K | ﹤0.01% | 5343 |
|
|
2024
Q1 | – | Sell |
-18,086
| Closed | -$26.6K | – | 6520 |
|
|
2023
Q4 | $26.6K | Sell |
18,086
-2,097
| -10% | -$3.08K | ﹤0.01% | 5641 |
|
|
2023
Q3 | $24.4K | Sell |
20,183
-24,176
| -55% | -$29.3K | ﹤0.01% | 5246 |
|
|
2023
Q2 | $64.3K | Buy |
44,359
+17,815
| +67% | +$25.8K | ﹤0.01% | 5151 |
|
|
2023
Q1 | $38.5K | Sell |
26,544
-24,105
| -48% | -$35K | ﹤0.01% | 5494 |
|
|
2022
Q4 | $87.6K | Sell |
50,649
-18,637
| -27% | -$32.2K | ﹤0.01% | 5004 |
|
|
2022
Q3 | $139K | Buy |
69,286
+15,141
| +28% | +$30.4K | ﹤0.01% | 5075 |
|
|
2022
Q2 | $40K | Sell |
54,145
-12,939
| -19% | -$9.56K | ﹤0.01% | 5293 |
|
|
2022
Q1 | $584K | Sell |
67,084
-8,099
| -11% | -$70.5K | ﹤0.01% | 3523 |
|
|
2021
Q4 | $1.2M | Buy |
75,183
+35,435
| +89% | +$567K | ﹤0.01% | 2608 |
|
|
2021
Q3 | $732K | Sell |
39,748
-1,710
| -4% | -$31.5K | ﹤0.01% | 3177 |
|
|
2021
Q2 | $579K | Sell |
41,458
-27,725
| -40% | -$387K | ﹤0.01% | 3715 |
|
|
2021
Q1 | $1.02M | Sell |
69,183
-4,895
| -7% | -$72K | ﹤0.01% | 2977 |
|
|
2020
Q4 | $1.44M | Buy |
74,078
+16,670
| +29% | +$323K | ﹤0.01% | 2107 |
|
|
2020
Q3 | $641K | Buy |
57,408
+17,158
| +43% | +$192K | ﹤0.01% | 2754 |
|
|
2020
Q2 | $545K | Buy |
+40,250
| New | +$545K | ﹤0.01% | 2837 |
|
|
2019
Q4 | – | Sell |
-11,063
| Closed | -$117K | – | 4745 |
|
|
2019
Q3 | $117K | Buy |
+11,063
| New | +$117K | ﹤0.01% | 4043 |
|